Premier Insurance Limited (PSX:PINL)
8.72
+0.62 (7.65%)
At close: Aug 1, 2025
Revance Therapeutics Balance Sheet
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Investments in Equity & Preferred Securities | 1,189 | 1,191 | 877.25 | 790.23 | 1,129 | 1,202 | Upgrade |
Other Investments | - | - | - | 71.23 | - | - | Upgrade |
Total Investments | 1,536 | 1,537 | 1,224 | 1,183 | 1,427 | 1,478 | Upgrade |
Cash & Equivalents | 65.29 | 65.99 | 40.69 | 57.88 | 91.29 | 41.29 | Upgrade |
Reinsurance Recoverable | 401.83 | 424.69 | 527.85 | 738.88 | 1,008 | 674.91 | Upgrade |
Other Receivables | 318.57 | 380.99 | 276.7 | 353.74 | 354.49 | 429.14 | Upgrade |
Property, Plant & Equipment | 204.84 | 206.51 | 196.59 | 205.21 | 213.57 | 221.74 | Upgrade |
Other Intangible Assets | 0.35 | 0.38 | 0.54 | 0.78 | 1.11 | 1.98 | Upgrade |
Other Current Assets | 120.95 | 146.41 | 92.41 | 145.41 | 201.81 | 191.39 | Upgrade |
Long-Term Deferred Tax Assets | 52.06 | 51.8 | 50.75 | 50.33 | 47.83 | 46.43 | Upgrade |
Long-Term Deferred Charges | 30.69 | 29.09 | 28.87 | 37.02 | 26.31 | 21.65 | Upgrade |
Other Long-Term Assets | 163.91 | 162.35 | 177.45 | 71.9 | 108.2 | 142.79 | Upgrade |
Total Assets | 2,894 | 3,006 | 2,616 | 2,844 | 3,479 | 3,249 | Upgrade |
Accrued Expenses | 147.52 | 150.43 | 159.01 | 190.32 | 196.51 | 197.8 | Upgrade |
Insurance & Annuity Liabilities | 635.22 | 667.74 | 469.77 | 411.41 | 420.33 | 548.93 | Upgrade |
Unpaid Claims | 510.05 | 490.71 | 607.49 | 897.21 | 1,027 | 700.57 | Upgrade |
Unearned Premiums | 240.38 | 310.94 | 285.98 | 359.39 | 341.84 | 299.07 | Upgrade |
Current Portion of Leases | - | 3.23 | 0.77 | 2.28 | 2.25 | 2.33 | Upgrade |
Long-Term Leases | 11.12 | 2.06 | 3.18 | 5.7 | 7.97 | 7.89 | Upgrade |
Other Current Liabilities | 36.42 | 36.42 | 36.44 | 39.25 | 39.49 | 39.51 | Upgrade |
Other Long-Term Liabilities | 145.9 | 139.12 | 98.88 | 75.22 | 104.08 | 110.98 | Upgrade |
Total Liabilities | 1,733 | 1,807 | 1,668 | 1,989 | 2,147 | 1,912 | Upgrade |
Common Stock | 505.65 | 505.65 | 505.65 | 505.65 | 505.65 | 505.65 | Upgrade |
Retained Earnings | 98.65 | 76.45 | 8 | -0.9 | 189.33 | 218.29 | Upgrade |
Comprehensive Income & Other | 557.34 | 616.95 | 433.74 | 350.66 | 637.41 | 612.97 | Upgrade |
Shareholders' Equity | 1,162 | 1,199 | 947.4 | 855.41 | 1,332 | 1,337 | Upgrade |
Total Liabilities & Equity | 2,894 | 3,006 | 2,616 | 2,844 | 3,479 | 3,249 | Upgrade |
Filing Date Shares Outstanding | 50.57 | 50.57 | 50.57 | 50.57 | 50.57 | 50.57 | Upgrade |
Total Common Shares Outstanding | 50.57 | 50.57 | 50.57 | 50.57 | 50.57 | 50.57 | Upgrade |
Total Debt | 11.12 | 5.29 | 3.95 | 7.97 | 10.22 | 10.22 | Upgrade |
Net Cash (Debt) | 54.18 | 60.7 | 36.74 | 49.9 | 81.07 | 31.07 | Upgrade |
Net Cash Growth | 177.42% | 65.23% | -26.38% | -38.44% | 160.93% | -63.97% | Upgrade |
Net Cash Per Share | 1.07 | 1.20 | 0.73 | 0.99 | 1.60 | 0.61 | Upgrade |
Book Value Per Share | 22.97 | 23.71 | 18.74 | 16.92 | 26.35 | 26.44 | Upgrade |
Tangible Book Value | 1,161 | 1,199 | 946.85 | 854.64 | 1,331 | 1,335 | Upgrade |
Tangible Book Value Per Share | 22.97 | 23.71 | 18.73 | 16.90 | 26.33 | 26.40 | Upgrade |
Land | - | 140.45 | 140.45 | 140.45 | 140.45 | 140.45 | Upgrade |
Buildings | - | 21.55 | 21.55 | 21.55 | 21.55 | 21.55 | Upgrade |
Machinery | - | 109.99 | 105.97 | 110.19 | 115.99 | 131.92 | Upgrade |
Construction In Progress | - | 26.11 | 26.11 | 26.11 | 26.11 | 26.11 | Upgrade |
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.